statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	570
RU - Federazione Russa	348
IT - Italia	167
SG - Singapore	161
CN - Cina	129
GB - Regno Unito	68
HK - Hong Kong	66
BR - Brasile	57
DE - Germania	53
IE - Irlanda	49
SE - Svezia	41
VN - Vietnam	35
FR - Francia	29
FI - Finlandia	25
KR - Corea	17
NL - Olanda	14
ES - Italia	12
IN - India	11
JP - Giappone	9
AT - Austria	8
ID - Indonesia	7
CA - Canada	6
MX - Messico	6
ZA - Sudafrica	6
TR - Turchia	5
PL - Polonia	4
TG - Togo	4
UA - Ucraina	4
BD - Bangladesh	3
BE - Belgio	3
BJ - Benin	3
IR - Iran	3
PK - Pakistan	3
PT - Portogallo	3
TW - Taiwan	3
AR - Argentina	2
AU - Australia	2
CO - Colombia	2
CZ - Repubblica Ceca	2
EE - Estonia	2
SA - Arabia Saudita	2
UZ - Uzbekistan	2
AL - Albania	1
AM - Armenia	1
AZ - Azerbaigian	1
BO - Bolivia	1
CH - Svizzera	1
CR - Costa Rica	1
DM - Dominica	1
EC - Ecuador	1
EG - Egitto	1
ET - Etiopia	1
HN - Honduras	1
HR - Croazia	1
IL - Israele	1
JM - Giamaica	1
JO - Giordania	1
KG - Kirghizistan	1
MA - Marocco	1
NZ - Nuova Zelanda	1
PE - Perù	1
PH - Filippine	1
PS - Palestinian Territory	1
RO - Romania	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
VE - Venezuela	1
Totale	1.974

Nome	#
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages	244
Unraveling the role of lymph node metastasis in PDAC and dCCA progression	193
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease	172
EVALUATION OF CANCER-STEM CELLS IN DIFFERENT MODELS OF PANCREATIC DUCTAL ADENOCARCINOMA	148
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC	142
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study	142
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models	140
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids	127
Loss of FGFR4 promotes the malignant phenotype of PDAC	126
Generation of Pancreatic Organoid-Derived Isografts	124
Preclinical Modelling of PDA: Is Organoid the New Black?	103
Long-term organoid culture of a small intestinal neuroendocrine tumor	102
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC	96
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer	78
The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model	77
Totale	2.014

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	72	0	0	0	0	17	15	2	8	0	2	5	23
2021/2022	112	7	30	7	2	9	10	7	9	6	2	5	18
2022/2023	233	11	29	24	38	15	55	0	19	25	6	9	2
2023/2024	177	3	14	14	14	20	23	9	17	1	27	29	6
2024/2025	514	20	22	29	77	26	35	30	25	89	35	45	81
2025/2026	720	76	44	101	203	296	0	0	0	0	0	0	0
Totale													2.014

CATALOGO DEI PRODOTTI DELLA RICERCA